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Abstract - In malaria, blood concentrations of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α) 
and interleukin (IL)-6, are increased. In a study which included 34 patients, TNF-α and IL-6 were examined in two phases, 
immediately after the admission of patients, and at the end of antimalarial therapy, when the parasitemia was negative. The 
results show a significant increase of TNF-α and IL-6 in the first phase, before the effects of antimalarial therapy. A very 
strong correlation between TNF-α and IL-6 is also confirmed, which suggests their coordinated production. Increased 
TNF-α values were correlated with an older age, the level of parasitemia, the number of platelets and leukocytes, elevated 
values of procalcitonin, D-dimer and lactate dehydrogenasе, and lower values of serum iron and antithrombin. Increased 
values of IL-6 were correlated with the level of parasitemia, the number of platelets and leukocytes, and elevated values of 
D-dimer and lactates.
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INTRODUCTION
Patients with malaria, especially in severe forms, 
have an increased concentration of proinflamma-
tory cytokines, of which TNF-α has been the most 
often examined (Chen et al., 2000). The increasing 
concentration of TNF-α in malaria was first re-
corded in 1986 (Scuderi et al., 1986). Kwiatkowski 
et al. (1989) demonstrated a significant increase 
in TNF-α levels in children with malaria in Gam-
bia. In malaria, as well as in other systemic infec-
tions and diseases, the release of proinflammatory 
cytokines produces a systemic inflammatory re-
sponse. Previous research related to sepsis and ma-
laria has shown that TNF-α, the prototype of proin-
flammatory cytokines, increased in both diseases, 
causing hyperlactatemia. It is well known that in-
creased regulation of proinflammatory cytokines in 
the process of adhesion to endothelial cells attracts 
circulating blood elements on the inner wall of the 
vessel (Sarangi et al., 2011). In many diseases, in-
cluding malaria, this includes activated leukocytes 
and platelets, which play an important role in pro-
coagulant activity. It is thought that proinflamma-
tory cytokines increase the expression of molecules 
on the endothelial cells adhered to by parasitizing 
1578 JASMINA POLUGA ET AL.
erythrocytes. Proinflammatory cytokines enhance 
the expression of tissue factor on the endothelial 
cells and monocytes, and by generating the occur-
rence of thrombin, a molecule with significant roles 
in cross-reactions of inflammation and coagulation 
(Clark et al., 2006). The speed, time and intensity 
of release of cytokines varies considerably in differ-
ent stages of the disease and between different in-
dividuals, thus forming a characteristic clinical fea-
ture. It is believed that proinflammatory cytokines 
are responsible for the occurrence of fever, nausea, 
vomiting, diarrhea, anorexia, myalgia, thrombo-
cytopenia, immunosuppression, coagulopathy and 
neurological manifestations (Jennings et al., 2006). 
In severe forms of malaria, the concentrations of 
proinflammatory cytokines, such as TNF-α, IL-1, 
IL-6, and IL-8, are elevated in the serum. The high 
level of TNF-α in patients with falciparum malaria 
correlates with the severity of the disease, with the 
appearance of hypoglycemia, hyperparasitemia, 
jaundice, kidney damage, cardiovascular complica-
tions and death (Mordmüller et al., 2007).
The aim of this study was to determine the serum 
levels of TNF-α and interleukin-6, and to establish 
their correlation with other clinical and laboratory 
parameters. 
MATERIALS AND METHODS
The study included 34 patients with imported ma-
laria who were treated from 2007 to 2010 at the 
Clinic of Infectious and Tropical Diseases, Clinical 
Center of Serbia. From the total number of patients, 
27 (79.41%) had falciparum malaria, while only 7 
(20.59%) had malaria caused by the other type of 
plasmodium (vivax ovale). 
The following data sources were used in this 
study: medical records, hematological, biochemical, 
parasitological and immunological analysis.
The most important parasitological analysis used 
in the study was the examination of thick and thin 
peripheral blood smears, stained with Giemsa. The 
level of parasitemia may be expressed either as a per-
centage of parasitized erythrocytes or as the number 
of parasites per microliter of blood. 
The immunological analyses of the cytokines 
(TNF-α and IL-6) were performed at the Center for 
Medical Biochemistry, Clinical Center of Serbia, us-
ing the method of Quantikine ELISA Kit (R&D Sys-
tems).
The serum samples of patients for cytokine anal-
ysis were taken in two stages: immediately after the 
admission and at the end of antimalarial therapy, 
when the parasitemia was negative. After centrifuga-
tion, they were separated and stored at -70˚C until 
use.
The method by which the cytokines were deter-
mined was the quantitative sandwich enzyme immu-
noassay technique. A monoclonal antibody specific 
for TNF-α/IL-6 was pre-coated onto a microplate. 
Standards and samples are pipetted into the wells and 
any TNF-α/IL-6 present was bound by the immo-
bilized antibody. After washing away any unbound 
substances, an enzyme-linked polyclonal antibody 
specific for TNF-α/IL-6 was added to the wells. Fol-
lowing a wash to remove any unbound antibody-
enzyme reagent, a substrate solution was added to 
the wells and color developed in proportion to the 
amount of TNF-α/IL-6 bound in the initial step. The 
color development was stopped and the intensity of 
the color was measured. 
The sensitivity (i.e. minimum detectable dose) of 
TNF-α was 1.6 pg/ml, and for IL-6, 0.70 pg /ml.
The following methods were used in statistical 
analysis: methods of descriptive statistics: mean val-
ue, standard deviation; Spearman’s rank correlation 
to determine the correlation between the levels of 
cytokines and the other clinical and laboratory pa-
rameters; analysis of variance (ANOVA) to compare 
the levels of TNF-α in patients with malaria in rela-
tion to the control values; Kolmogorov-Smirnov test 
and Mann-Whitney test were used to compare the 
levels of IL-6 in patients with malaria in relation to 
the control values.
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Fig. 1. Correlation on TNF-a with IL-6, the age and laboratory parameters in the first phase (1)
Fig. 2. Correlation on IL-6 with TNF-a, the age and laboratory parameters in the first phase (1)
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RESULTS
The study included 34 patients. The cytokines TNF-α 
and IL-6 were examined at two phases: immediately 
after the admission of patients (1) and at the end of 
antimalarial therapy, when the parasitemia was nega-
tive (2). 
Using the methods of statistical analysis (ANO-
VA, Kolmogorov-Smirnov and Mann-Whitney 
test) we have proved the increased values of TNF-α 
(p=0.027) and IL-6 (p=0.006) in the first phase. 
The ANOVA test confirmed that there was no 
statistically significant difference in the values of 
TNF-α (p=0.974) and IL-6 (p=0.827) between the 
two phases, i.e. before and after treatment.
Additional laboratory parameters were also tak-
en in each phase to determine the correlation and 
for monitoring dynamics in relation to the values of 
cytokines.
The values of D-dimer and C-reactive protein 
(CRP) were increased in the first phase, while the 
values of antithrombin III (AT3) and lactates were in 
the reference range. 
In the second phase, there was a decrease in the 
value of laboratory parameters of the first phase, D-
dimer and CRP. The values of AT3 and lactates were 
increased, but within the reference range.
The results show that there is a very strong cor-
relation between TNF and IL-6 in the first phase. 
Increased TNF-α levels correlated with an older age, 
the level of parasitemia, as did the elevated values of 
procalcitonin, D-dimer and LDH, but also with the 
lower values of platelets, leukocytes, serum iron, AT3 
and Hb.
The increased values of IL-6 correlated with the 
level of parasitemia, elevated values of D-dimer and 
lactates. A negative correlation was observed for 
thrombocytopenia and leucopenia. Unlike the TNF-α, 
elevated values of IL-6 poorly correlated with age.   
The values of TNF-α in the second phase strong-
ly correlated with the number of platelets. The val-
ues of IL-6 in the second phase strongly correlated 
with the value of D-dimer. It was concluded that in 
the first phase, before starting treatment, TNF-α and 
IL-6 correlated more with the laboratory parameters 
of the same phase.
DISCUSSION
The role of cytokines in the pathogenesis of malar-
ia has been clearly confirmed, but not completely 
understood. It is thought that many factors impact 
on their level, which in the course of malaria de-
pends on the circadian rhythm, and in accordance 
with this, there are large variations in the serum 
cytokine levels. TNF-α appears to be the most im-
portant in the early immune response and sub-
sequent pathological manifestations. It has been 
proved that its concentration regulates the levels of 
the other cytokines as well, particularly in relation 
to IL-6 (Angulо and Fresno, 2002). Thus we could 
explain the results of this study, where the levels of 
TNF-α correlated to a high degree with other lab-
oratory parameters in relation to IL-6, especially 
when taking into account the parameters that in-
dicate the more difficult forms of disease (anemia, 
thrombocytopenia, high value of LDH). The results 
show a significant increase in TNF-α and IL-6 in 
the first phase, in the presence of parasitemia, and 
before the effects of antimalarial therapy. In addi-
tion, there is a very strong correlation between the 
levels of TNF-α and IL-6 in the first phase and their 
significant association with the level of parasitemia. 
Many other authors have also established their mu-
tual coordination and association with the degree 
of parasitemia in patients with malaria (Shaffer et 
al., 1991; McGuire et al., 1998; Zeyrek et al., 2006).
According to a study from Hamburg (Kern et al., 
1989), an increase in TNF-α and IL-6 was observed 
mainly in patients with falciparum malaria, while the 
concentrations of TNF-α and IL-6 correlated with the 
degree of parasitemia and the occurrence of compli-
cations. Thereby, they found a correlation between 
increased levels of these cytokines and anemia, hy-
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poglycemia, hyperbilirubinemia and acute renal fail-
ure, which is consistent with the results of this study. 
A study from Pakistan showed almost identical re-
sults in falciparum malaria, but there was no cor-
relation with the degree of parasitemia (Gandapuр 
and Malik, 1996). Research conducted in Mali, in pa-
tients with falciparum malaria, showed a significant 
increase in cytokines in patients, including TNF-α 
and IL-6, but the correlation between hyperpara-
sitemia and anemia with increased concentrations of 
IL-6 has not been proven (Lyke et al., 2004). 
In the enlisted patients, increased levels of 
cytokines were in a stronger (TNF-α) or weaker 
(IL-6) correlation with the age. Authors from Pa-
kistan (Gandapuр and Malik, 1996) indicated that 
Table 1. The values  of cytokines in the first (1) and second (2) phase
Type of cytokines Mean value (pg/ml) SD
 TNF-α  (1)   21.03  17.39
  IL-6  (1)   31.70  39.25
 TNF-α  (2)   5.17  3.59
  IL-6  (2)   7.46  6.32
 
Table 2. The values of cytokines of the controls
 Type of cytokines Mean value (pg/ml) SD
 TNF-α   5.73 2.38
  IL-6   3.92 2.19
Table 3. The values  of additional laboratory parameters (phase 1)
Laboratory parameters Mean value SD
 D-dimer 765.36 917.01
 Antithrombin III (AT3) 85.55 18.01
 Lactates 1.33 0.61
 C-reactive protein (CRP) 114.41 84.88
Table 4. The values  of additional laboratory parameters (phase 2)
Laboratory parameters Mean value SD
D-dimer 211.40 142.16
Antithrombin III (AT3) 100.32 13.76
Lactates  1.52 0.69
C-reactive protein (CRP) 49.43 116.03
Table 5. Correlation of TNF-α and IL-6 in the second phase (2)
Type of cytokines   Laboratory parameters R p
TNF-α   (2) Platelets (2) (**) -0.472 0,015
IL -6   (2) D-dimer  (2) (**) 0.531 0.006
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the concentrations of TNF-α in children with fal-
ciparum malaria increased with age, whereas in 
adults there was no difference. Studies show that 
the concentrations of inflammatory mediators in 
serum/plasma, such as cytokines and acute phase 
proteins, increase with aging. The levels of circulat-
ing cytokines TNF-α and IL-6 are associated with 
morbidity and mortality in old age, and considered 
to cause or to exacerbate the risk factors in patho-
logical conditions related to the age (Bruunsgaard 
et al., 2001; Krabbe et al., 2004). It is thought that 
in a relatively healthy elderly population, increas-
ing levels of circulating IL-6 present a systemic 
response to local proinflammatory activity; how-
ever, when inflammatory diseases associated with 
old age progress, the level of circulating TNF-α 
increases, which gradually becomes a stronger 
marker of morbidity than IL-6 (Brüünsgaard and 
Pedersen, 2003). 
The increased levels of TNF-α and IL-6 correlate 
with thrombocytopenia and a high concentration of 
D-dimer in both phases, i.e. before and after treat-
ment, which is consistent with the pathophysiologi-
cal mechanisms that occur in the course of this dis-
ease. In fact, the activation of the coagulation system 
leads to the appearance of fibrin degradation prod-
ucts (FDP), i.e. D-dimer in the circulation, which we 
found in malaria as well, mainly in those caused by 
Plasmodium falciparum. Initiation of the coagulation 
cascade and fibrinolytic system is caused by parasi-
tized erythrocytes and/or activated platelets (Fran-
cischetti, 2008; Ghosh and Shetty, 2008). Parasitized 
erythrocytes adhere to the capillary endothelium, 
causing further activation which results in plate-
let consumption and the activation of coagulation, 
which may culminate in the appearance of DIC (dis-
seminated intravascular coagulation). IL-6 stimu-
lates platelets, which are manifested by an increased 
activation of thrombin and increased procoagulant 
activity, and coagulation markers detect changes 
as a response to the effects of TNF-α (Esmon et al., 
1999). In the first phase, we found strong correlation 
between TNF-α and AT3, whose values are often 
reduced in falciparum malaria, especially its severe 
forms.
These results are expected when we have in mind 
the pathophysiological mechanism in which cytokine 
production and parasitized erythrocytes cause the 
consumption of AT3  (Mohanty et al., 1997). In con-
trast to the correlation of TNF-α and AT3, in the first 
phase we registered a correlation between increased 
levels of IL-6 and the increase of lactates. Some au-
thors also find an association between increased 
concentrations of IL-6 and IL-10 and lactates, before 
starting antimalarial therapy (Day et al., 1999). 
Sarthou et al. (1997) have shown a decline in 
the concentrations of TNF-α and IL-6 after anti-
malarial treatment. According to the results of this 
study, the average values of TNF-α and IL-6 in the 
second phase were much lower than values before 
therapy, but the difference in values was not statis-
tically significant. The time interval between the 
determination of cytokine concentrations before 
and after treatment, i.e. during the presence or ab-
sence of parasitemia, was an average of 7 days, but 
for some patients this period was shorter. Specifi-
cally, these were patients who were taking antima-
larial therapy on their own initiative, and the time 
of treatment was shorter. Most probably, this is the 
reason for the observed disparities between the lev-
els of cytokines before and after treatment. Namely, 
after the therapy, they were generally reduced in all 
patients, albeit not equally.
REFERENCES
Angulo, I. and M. Fresno (2002). Cytokines in the pathogenesis of 
and protection against malaria. Clin Diagn Lab Immunol. 
9 (6), 1145-1152.
Brüünsgaard, H. and B.K. Pedersen (2003). Age-related inflam-
matory cytokines and disease. Immunol Allergy Clin North 
Am. 23 (1), 15-39.
Brüünsgaard, H., Pedersen, M. and B.K. Pedersen (2001). Aging 
and proinflammatory cytokines. Curr Opin Hematol. 8 
(3), 131-136. 
Chen, Q., Schlichtherle, M. and M.Wahlgren (2000). Molecular 
aspects of severe malaria. Clin Microbiol Rev. 13 (3), 439-
450.
Clark, I.A., Budd, A.C., Alleva L.M. and W.B. Cowden (2006). 
Human malarial disease: a consequence of inflammatory 
cytokine release. Malar J. 5, 85.
INCREASED TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN-6 SERUM LEVELS 1583
Day, N.P., Hien, T.T., Schollaardt, T., Loc, P.P., Chuong, L.V., Chau, 
T.T., Mai, N.T., Phu, N.H., Sinh, D.X., White, N.J. and M. 
Ho (1999). The prognostic and pathophysiologic role of 
pro- and antiinflammatory cytokines in severe malaria. J 
Infect Dis. 180 (4), 1288-1297.
Esmon, C.T. (1999). Possible involvement of cytokines in diffuse 
intravascular coagulation and thrombosis. Best Pract Res 
Clin Haematol. 12 (3), 343-359.
Francischetti, I.M. (2008). Does activation of the blood coagula-
tion cascade have a role in malaria pathogenesis? Trends 
Parasitol. 24 (6), 258-263.  
Gandapur, A.S. and S.A.Malik (1996). Tumor necrosis factor in 
falciparum malaria. Ann Saudi Med. 16 (6), 609-614.
Ghosh, K and S. Shetty (2008). Blood coagulation in falciparum 
malaria – a review. Parasitol Res. 102 (4), 571-576.
Jennings, R.M., DE Souza, J.B., Todd, J.E., Armstrong, M., Flana-
gan, K.L., Riley, E.M. and J.F. Doherty (2006). Imported 
Plasmodium falciparum malaria: are patients originating 
from disease-endemic areas less likely to develop severe 
disease? A prospective, observational study. Am J Trop 
Med Hyg. 75 (6),1195-1199. 
Kern, P., Hemmer, C.J., Van Damme, J., Gruss H.J. and M. Dietrich 
(1989). Elevated tumor necrosis factor alpha and interleu-
kin-6 serum levels as markers for complicated Plasmodi-
um falciparum malaria. Am J Med. 87 (2), 139-143.
Krabbe, K.S., Pedersen, M. and H.Bruunsgaard (2004). Inflam-
matory mediators in the elderly. Exp Gerontol. 39 (5), 
687-699.
Kwiatkowski, D., Cannon, J.G., Manogue, K.R., Cerami, A., Din-
arello, C.A. and B.M. Greenwood (1989). Tumour necrosis 
factor production in Falciparum malaria and its associa-
tion with schizont rupture. Exp Immunol. 77 (3), 361-366. 
Lyke, K.E., Burges, R., Cissoko, Y., Sangare, L., Dao, M., Diarra, I., 
Kone, A., Harley, R., Plowe, C.V., Doumbo, O.K. and M.B. 
Sztein (2004). Serum levels of the proinflammatory cytok-
ines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor 
necrosis factor alpha, and IL-12(p70) in Malian children 
with severe Plasmodium falciparum malaria and matched 
uncomplicated malaria or healthy controls. Infect Immun. 
72 (10), 5630-5637.
McGuire, W., D’Alessandro, U., Stephens, S., Olaleye, B.O., 
Langerock, P. and B.M. Greenwood (1998). Levels of tu-
mour necrosis factor and soluble TNF receptors during 
malaria fever episodes in the community. Trans R Soc Trop 
Med Hyg. 92 (1), 50-53
Mohanty, D., Ghosh, K., Nandwani, S.K., Shetty, S., Phillips, C., 
Rizvi, S. and B.D. Parmar (1997). Fibrinolysis, inhibitors 
of blood coagulation, and monocyte derived coagulant ac-
tivity in acute malaria. Am J Hematol. 54 (1), 23-29.
Mordmüller, B.G., Metzger, WG, Juillard, P., Brinkman, B.M., Ver-
weij, C.L., Grau, G.E., Kremsner, P.G. and N.D.Phuc (1997). 
Tumor necrosis factor in Plasmodium falciparum malaria: 
high plasma level is associated with fever, but high pro-
duction capacity is associated with rapid fever clearance. 
Eur Cytokine Netw. 8 (1), 29-35.
Sarangi, A., Monapathra, P.C. and R.K. Dalai (2011). Serum cy-
tokine levels of IL-12, IL-4 and TNF-alpha in malaria: a 
study from the coastal districts of Odisha. Journal of Cell 
and Tissue Research 11 (2), 2873-2878. 
Sarthou, J.L., Angel, G., Aribot, G., Rogier, C., Dieye, A., Toure-
Balde, A., Diatta, B., Seignot, P. and C.Roussilhon (1997). 
Pronostic value of anti-Plasmodium falciparum-specific 
immunoglobulin G3, cytokines and their soluble recep-
tors in West African patients with severe malaria. Infect 
Immun. 65, 3271-3276.
Scuderi, P., Sterling, K.E., Lam, K.S., Finley, P.R., Ryan, K.J., Ray, 
C.G., Petersen, E., Slymen, D.J. and S.E. Salmon (1986). 
Raised serum levels of tumour necrosis factor in parasitic 
infections. Lancet 2 (8520), 1364-1365.
Shaffer, N., Grau, G.E., Hedberg, K., Davachi, F., Lyamba, B., 
Hightower, A.W., and J.G.Breman (1991). Tumor necrosis 
factor and severe malaria. J Infect Dis. 163 (1), 96-101.
Zeyrek, F.Y., Kurcer, M.A., Zeyrek, D. and Z.Simsek (2006). Para-
site density and serum cytokine levels in Plasmodium 
vivax malaria in Turkey. Parasite Immunol. 28 (5), 201-
207.

